Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio
Hunan Warrant Pharmaceutical Co. Ltd. A cash flow-to-debt ratio. Hunan Warrant Pharmaceutical Co. Ltd. A (688799) has a Cash Flow-to-Debt Ratio of 0.22x as of December 2024, meaning its operating cash flow of CN¥142.23 Million could theoretically repay 0% of its total liabilities (CN¥637.06 Million) in one year. Check total reinvestment intensity of Hunan Warrant Pharmaceutical Co. Ltd. A to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Hunan Warrant Pharmaceutical Co. Ltd. A (2019–2024)
Cash flow-to-debt ratio of Hunan Warrant Pharmaceutical Co. Ltd. A from 2019 to 2024. Historical debt coverage capacity for Hunan Warrant Pharmaceutical Co. Ltd. A across 6 annual periods. Check 688799 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Hunan Warrant Pharmaceutical Co. Ltd. A Cash Flow-to-Debt Ratio by Year (2019–2024)
Hunan Warrant Pharmaceutical Co. Ltd. A cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Hunan Warrant Pharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see Hunan Warrant Pharmaceutical Co. Ltd. A (688799) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.22x | CN¥142.23 Million | CN¥637.06 Million | ▼ -57.5% |
| 2023 | 0.52x | CN¥214.44 Million | CN¥408.70 Million | ▲ +18.1% |
| 2022 | 0.44x | CN¥155.65 Million | CN¥350.35 Million | ▲ +23.2% |
| 2021 | 0.36x | CN¥114.72 Million | CN¥318.07 Million | ▼ -11.1% |
| 2020 | 0.41x | CN¥104.66 Million | CN¥258.07 Million | ▲ +3.7% |
| 2019 | 0.39x | CN¥116.66 Million | CN¥298.27 Million | — |